Standards for the Uniform Reporting of Hypertension in Adults Using Population Survey Data: Recommendations From the World Hypertension League Expert Committee

Journal of Clinical Hypertension

Volumn 16, Issue 11, 2014, Pages 773-781

  Gee, Marianne E ^a   Campbell, Norm ^b,c   Sarrafzadegan, Nizal ^d   Jafar, Tazeen ^e,f,g,h   Khalsa, Tej K ⁱ   Mangat, Birinder ⁱ   Poulter, Neil ^j   Prabhakaran, Dorairaj ^k,l   Sonkodi, Sandor ^m   Whelton, Paul K ⁿ   Woodward, Mark ^o,p,q   Zhang, Xin Hua ^c,r  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c World Hypertension League   (Canada)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f SINGAPORE GENERAL HOSPITAL   (Singapore)

^g TUFTS MEDICAL CENTER   (United States)

^h AGA KHAN UNIVERSITY   (Pakistan)

ⁱ UNIVERSITY OF CALGARY   (Canada)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

^k CENTRE FOR CHRONIC DISEASE CONTROL   (India)

^l PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^m UNIVERSITY OF SZEGED   (Hungary)

ⁿ TULANE UNIVERSITY   (United States)

^o UNIVERSITY OF OXFORD   (United Kingdom)

^p UNIVERSITY OF SYDNEY   (Australia)

^q JOHNS HOPKINS UNIVERSITY   (United States)

^r Beijing Hypertension League Institute   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; AWARENESS; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CLINICAL INDICATOR; DATA ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE SURVEILLANCE; HUMAN; HYPERTENSION; INFORMATION PROCESSING; MEDICAL SERVICE; MEDICAL SOCIETY; MEDICATION THERAPY MANAGEMENT; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; ADOLESCENT; ADVISORY COMMITTEE; AGED; HEALTH; HEALTH CARE PLANNING; HEALTH SURVEY; MIDDLE AGED; PROCEDURES; STANDARDS;

ADOLESCENT; ADULT; ADVISORY COMMITTEES; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; DATA COLLECTION; GLOBAL HEALTH; HEALTH PLANNING GUIDELINES; HUMANS; HYPERTENSION; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 84919616407     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12387     Document Type: Article

References (44)

1. Alwan A, Maclean DR, Riley LM, et al. Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries. Lancet. 2010;376:1861-1868.
2. Campbell NR, McAlister FA, Quan H; Hypertension Outcomes Research Task Force. Monitoring and evaluating efforts to control hypertension in Canada: why, how, and what it tells us needs to be done about current care gaps. Can J Cardiol. 2013;29:564-570.
3. World Health Organization. Global Action Plan for the Prevention and Control of NCDs 2013-2020. Vol 2014. Geneva: World Health Organization; 2013. http://www.who.int/nmh/events/ncd_action_plan/en/ed. Accessed May 1, 2014.
4. Burroughs Pena MS, Mendes Abdala CV, Silva LC, Ordunez P. Usefulness for surveillance of hypertension prevalence studies in Latin America and the Caribbean: the past 10 years. Rev Panam Salud Publica. 2012;32:15-21.
5. Ordunez P, Silva LC, Rodriguez MP, Robles S. Prevalence estimates for hypertension in Latin America and the Caribbean: are they useful for surveillance? Rev Panam Salud Publica. 2001;10:226-231.
6. Silva LC, Ordunez P, Paz Rodriguez M, Robles S. A tool for assessing the usefulness of prevalence studies done for surveillance purposes: the example of hypertension. Rev Panam Salud Publica. 2001;10:152-160.
7. Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123:894-900.
8. Okura Y, Urban LH, Mahoney DW, et al. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol. 2004;57:1096-1103.
9. Martin LM, Leff M, Calonge N, et al. Validation of self-reported chronic conditions and health services in a managed care population. Am J Prev Med. 2000;18:215-218.
10. Bush TL, Miller SR, Golden AL, Hale WE. Self-report and medical record report agreement of selected medical conditions in the elderly. Am J Public Health. 1989;79:1554-1556.
11. Kehoe R, Wu SY, Leske MC, Chylack LT Jr. Comparing self-reported and physician-reported medical history. Am J Epidemiol. 1994;139:813-818.
12. Wada K, Yatsuya H, Ouyang P, et al. Self-reported medical history was generally accurate among Japanese workplace population. J Clin Epidemiol. 2009;62:306-313.
13. Tormo MJ, Navarro C, Chirlaque MD, Barber X. Validation of self diagnosis of high blood pressure in a sample of the Spanish EPIC cohort: overall agreement and predictive values. EPIC group of Spain. J Epidemiol Community Health. 2000;54:221-226.
14. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-313.
15. Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004;44:398-404.
16. Olives C, Myerson R, Mokdad AH, et al. Prevalence, awareness, treatment, and control of hypertension in United States counties, 2001-2009. PLoS One. 2013;8:e60308.
17. World Health Organization. WHO STEPS Surveillance Manual: The WHO STEPwise Approach to Chronic Disease Risk Factor Surveillance. Geneva: World Health Organization; 2005.
18. Ahmad OB, Boschi-Pinto C, Lopez AD, et al. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series, World Health Organization. 2001;31.
19. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31-40.
20. Chokshi NP, Grossman E, Messerli FH. Blood pressure and diabetes: vicious twins. Heart. 2013;99:577-585.
21. Franjic B, Marwick TH. The diabetic, hypertensive heart: epidemiology and mechanisms of a very high-risk situation. J Hum Hypertens. 2009;23:709-717.
22. Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet. 2012;380:601-610.
23. World Health Organization. Rio political declaration on social determinants of health. http://www.who.int/sdhconference/declaration/Rio_political_declaration.pdf?ua=1. Updated 2011. Accessed March 28, 2014.
24. World Health Organization. Prevention of Cardiovascular Disease: Guidelines for Assessment and Management of Cardiovascular Risk. Geneva: World Health Organization; 2007.
25. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-520.
26. Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014;16:14-26.
27. Hackam DG, Quinn RR, Ravani P, et al. The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2013;29:528-542.
28. Krause T, Lovibond K, Caulfield M, et al. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:d4891.
29. Sanchez RA, Ayala M, Baglivo H, et al. Latin American guidelines on hypertension. Latin American expert group. J Hypertens. 2009;27:905-922.
30. Guo X, Zhang X, Guo L, et al. Association between pre-hypertension and cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Curr Hypertens Rep. 2013;15:703-716.
31. World Health Organization. Package of Essential Noncommunicable (PEN) Disease Interventions For Primary Health Care in Low-Resource Settings. Vol 2014. Geneva: World Health Organization; 2013. http://apps.who.int/medicinedocs/en/d/Js19715en/ed. Accessed May 1, 2014.
32. Mendis S, Lindholm LH, Mancia G, et al. World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. J Hypertens. 2007;25:1578-1582.
33. Dugee O, Oum S, Buckley BS, Bonita R. Assessment of total cardiovascular risk using WHO/ISH risk prediction charts in three low and middle income countries in Asia. BMC Public Health. 2013;13:539.
34. Liew SM, Doust J, Glasziou P. Cardiovascular risk scores do not account for the effect of treatment: a review. Heart. 2011;97:689-697.
35. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-1252.
36. McAlister FA, Lewanczuk RZ, Teo KK. Resistant hypertension: an overview. Can J Cardiol. 1996;12:822-828.
37. Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension. 2011;57:1076-1080.
38. World Health Organization. Draft comprehensive global monitoring framework and targets for prevention and control of noncommunicable diseases. http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_8-en.pdf?ua=1. Updated 2013. Accessed March 28, 2014.
39. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 2013;36(suppl 1):S11-S66.
40. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich). 2005;7:102-109.
41. Padfield PL. Measuring blood pressure: who and how? J Hypertens. 2009;27:216-218.
42. Taylor J. 2013 ESH/ESC guidelines for the management of arterial hypertension. Eur Heart J. 2013;34:2108-2109.
43. O'Brien E, Asmar R, Beilin L, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003;21:821-848.
44. O'Brien E, Asmar R, Beilin L, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23:697-701.